Sands Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Sands Capital Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,875	Closed	-$653K	–	79
2021 Q1	$653K	Sell	1,875 -325,596	-99%	-$108M	﹤0.01%	75
2020 Q4	$84.6M	Sell	327,471 -139,124	-30%	-$38.3M	0.16%	61
2020 Q3	$134M	Buy	466,595 +109,754	+31%	+$25.8M	0.29%	53
2020 Q2	$67.2M	Buy	356,841 +18,475	+5%	+$3.01M	0.16%	57
2020 Q1	$41.7M	Buy	338,366 +171,443	+103%	+$26.8M	0.14%	61
2019 Q4	$27.7M	Sell	166,923 -97,309	-37%	-$16.2M	0.08%	67
2019 Q3	$32.4M	Buy	264,232 +8,416	+3%	+$1.12M	0.1%	61
2019 Q2	$31.7M	Buy	255,816 +14,958	+6%	+$1.9M	0.09%	61
2019 Q1	$31.8M	Sell	240,858 -4,339	-2%	-$585K	0.1%	50
2018 Q4	$34.4M	Buy	245,197 +151,354	+161%	+$20.1M	0.12%	49
2018 Q3	$16.2M	Buy	+93,843	New	+$15.8M	0.05%	52

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sands Capital Management's ONC Position: Q2 2021 in Review

Sands Capital Management sold out of BeOne Medicines Ltd (ONC) in Q2 2021, closing a stake of 1,875 shares — an estimated $653K sold.

Sands Capital Management first reported a position in ONC in Q3 2018 and held it in 11 quarters. The position peaked at $134M in Q3 2020. 268 funds tracked by Wall St. Rank hold ONC as of Q2 2021.

Sands Capital Management reported no remaining BeOne Medicines Ltd position as of Q2 2021 after selling out during the quarter.
Sands Capital Management sold 1,875 BeOne Medicines Ltd shares in Q2 2021, an estimated $653K.
Sands Capital Management first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 11 quarters.
Sands Capital Management's BeOne Medicines Ltd position peaked at $134M in Q3 2020.
268 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2021.

Based on Sands Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.